SOPHiA GENETICS SA (SOPH) research
SOPHiA GENETICS SA- Sector
- Healthcare
- Industry
- Health Information Services
- Last price
- $8.07
- As of
SOPHiA GENETICS SA (SOPH): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-08-04.
As of . Source: SEC EDGAR filings for SOPH. Method and limitations.
Share the SOPH intelligence card
See the full SOPH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SOPH on one page. Preview it with sample data, then open it live with a free account.
Preview the SOPH dossierActive signals for SOPH
- highCONSENSUS_BUY
5 tracked funds increased SOPH this 2026Q2, institutional consensus
- highCONSENSUS_BUY
4 tracked funds increased SOPH this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +1265% to SOPH (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +89% to SOPH (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +1107% to SOPH (2026Q2)
FREE, NO ACCOUNT
Every signal on SOPH, as it fires
You are seeing 5 of 14 signals recorded on SOPH since 2026-05-30.
The five above landed across 2 days. The other 9 were recorded on 3 other days. 7 of the 14 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in SOPH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP H82027105 · 2026Q2 | $799K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP H82027105 · 2026Q2 | $654K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP H82027105 · 2026Q2 | $337K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP H82027105 · 2026Q2 | $222K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SOPH
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
SOPH against its peers
SOPH's operating margin of -91.8% ranks in the 13th percentile of 18 Health Information Services sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-31.
| Metric | SOPH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 77.3M USD | 185M USD | 24 | 18 |
| Revenue YoY | 18.6% | n/a | n/a | 3 |
| Gross margin | 67.4% | 67.3% | 54 | 11 |
| Operating margin | -91.8% | -8.4% | 13 | 18 |
| Net margin | -102.2% | -13.8% | 13 | 18 |
| Return on equity | -167.6% | -22.0% | 13 | 18 |
| P / E | n/a | 30.0x | n/a | 7 |
Peers (20): PHR, WEAV, NRC, TBRG, CARL, SY, AMWL, SDGR, OPRX, HCAT, LFMD, HTFL, CCLD, RVRC, DRIO, HQY, VASO, ONMD, BEAT, CRVW. Left out: HYDTF (no annual filing), RNLXY (period gap), DGNOF (no annual filing), VRHI (no annual filing), PMDIY (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (SOPH: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more SOPH signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SOPHand get the insider, 13F, options, and confluence read in one view.